Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25288766 | 0.84 | TSHR (0.33) | NLRP3CA12CA1CA2CA7 | |
| SCHEMBL24141568 | 0.83 | TSHR (0.43) | NLRP3TSHR | |
| SCHEMBL19419016 | 0.78 | TSHR (0.32) | TSHR | |
| SCHEMBL19419168 | 0.78 | TSHR (0.32) | TSHR | |
| SCHEMBL23865769 | 0.78 | CA1 (0.41) | CA12CA1CA2CA7CA14 | |
| SCHEMBL18563091 | 0.70 | CA2 (0.35) | CA12CA1CA2CA7CA14 | |
| SCHEMBL20376269 | 0.68 | TP53 (0.43) | CA12CA1CA2CA7CA14 | |
| SCHEMBL27666933 | 0.68 | TSHR (0.37) | CA2TSHR | |
| SCHEMBL28520747 | 0.68 | TSHR (0.43) | CA12CA1CA2CA7CA14 | |
| SCHEMBL8812287 | 0.68 | CA1 (0.46) | CA12CA1CA2CA7CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11721838-B2 | Electrolyte and electrochemical apparatus | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2023-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11721838-B2 | Electrolyte and electrochemical apparatus | HCN2, HCN3, KCNH3 | NLRP3 4344/4885CA12 157/4885CA1 90/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.